Peer-influenced content. Sources you trust. No registration required. This is HCN.

The New England Journal of MedicineFifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

A total of 1,643 men with localized prostate cancer were enrolled in a trial to assess treatment efficacy, with 545 randomly assigned to active monitoring, 553 to prostatectomy, and 545 to radiotherapy. Prostate cancer-specific mortality was low after 15 years of follow-up, regardless of treatment. Thus, deciding on therapy entails weighing the benefits and drawbacks of treatments for localized prostate cancer.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form